Background: The American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), revising the National Cholesterol Evaluation Program for Adult Treatment Panel III (NCEP ATP III), and the International Diabetes Federation (IDF) have proposed defi nitions of metabolic syndrome that take into account waist circumference thresholds according to ethnicity. In this study we estimated the prevalence of metabolic syndrome in a Japanese-Brazilian population using NCEP defi nitions for Westerners (NCEPwe) and Asians (NCEPas), and IDF for Japanese (IDF). Methods: A total of 650 Japanese-Brazilians living in a developed Brazilian city and aged 30-88 years were included. Results: Metabolic syndrome prevalence according to NCEPwe, NCEPas, and IDF was, respectively, 46.5%, 56.5%, and 48.3%. Only 43.5% of subjects did not have metabolic syndrome by any of the 3 defi nitions, and 38.3% fulfi lled metabolic syndrome criteria for all 3 defi nitions. Ten percent of subjects were positive for metabolic syndrome based on NCEPas and IDF, but not for NCEPwe. Because IDF requires abdominal obesity as a criterion, the frequency of subjects without metabolic syndrome according to IDF, but with metabolic syndrome by NCEPwe and NCEPas was 8.2%. Conclusions: Independent of the metabolic syndrome defi nition, Japanese-Brazilians present an elevated metabolic syndrome prevalence, which was higher when using NCEP criteria for Asians, followed by the IDF defi nition for Japanese.
Introduction

M
etabolic syndrome encompasses several components that predispose individuals to a higher risk of cardiovascular events, such as coronary artery disease, myocardial infarction, heart failure, and encephalic vascular accident, contributing to increased cardiovascular morbimortality. 1 Patients with metabolic syndrome are also at increased risk of developing type 2 diabetes mellitus (T2DM). 2 An essential component involved in the metabolic syndrome pathophysiology appears to be insulin resistance, with consequent hyperinsulinemia resulting mainly from excessive circulating free fatty acids. Obesity, particularly the visceral variety, has been considered a key component for developing insulin resistance. 3, 4 Asians have a greater tendency than Caucasians to deposit adipose tissue as abdominal visceral fat rather than abdominal subcutaneous fat. 5, 6 Probably due to increased intraabdominal fat deposition, Japanese are susceptible to T2DM and cardiovascular disease despite a relatively normal body mass index (BMI). 5, 6 Taking this into account, the International Diabetes Institute (IDI), a center that collaborates with the World Health Organization (WHO), proposed specifi c values to characterize total and abdominal obesity in Asian populations. Subjects with BMI values between 25.0 and 29.9 kg/m 2 and BMI ≥30.0 kg/m 2 were classifi ed as I and II degree obesity, respectively, and associated with moderate and severe risk for developing co-morbidities. Central obesity was defi ned as waist circumference ≥90 cm in men and ≥80 cm in women.
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and the iliac crest. Arterial blood pressure readings were measured with an automatic Omron automatic apparatus (HEM-712C, Omron Health Care Inc., Vernon Hills, IL). Venous blood was obtained after an overnight fast of at least 10 h. Glycemia and lipid fractions were measured using an automation kit system and apparatus from BoehringerMannheim ® (Germany). Results of BMI classifi cation and risk for developing co-morbidities are presented and discussed based on the IDI criteria for Asian populations. 7 
Defi nitions of metabolic syndrome
Subjects were considered to have metabolic syndrome according to NCEPwe and NCEPas when 3 or more of the following criteria were present 2 : fasting glycemia ≥100 mg/ dL or under drug treatment for diabetes mellitus; systolic arterial blood pressure (SBP) ≥130 mmHg and/or diastolic arterial blood pressure (DBP) ≥85 mmHg or under drug treatment for arterial hypertension; triglycerides (TG) ≥150 mg/dL or receiving drug treatment for dyslipidemia; highdensity lipoprotein cholesterol (HDL-C) <40 mg/dL in men and <50 mg/dL in women or under drug treatment for dyslipidemia; waist circumference ≥102 cm in men and ≥88 cm in women for NCEPwe, and waist circumference ≥90 cm in men and ≥80 cm in women for NCEPas. The IDF defi nition of metabolic syndrome for Japanese subjects differs from NCEPas only for the requirement for waist circumference to be increased, in addition to the presence of at least 2 of the other criteria. 8 
Statistical analysis
Age, weight, height, BMI, and separated components of metabolic syndrome are expressed as mean and standard deviation (SD). Metabolic syndrome prevalence is presented in descriptive form. The nonpaired Student t-test was used for comparisons of age and BMI between genders. The prevalence of metabolic syndrome components according to gender and waist circumference was analyzed by the Goodman test for contrasts between and within multinomial populations. 13 All data were evaluated at a P level of 5%.
Results
There was no difference between ages for men and women (60.6 ± 13.3 and 60.0 ± 11.9 years, respectively). For the 650 study participants, mean body weight was 61.4 ± 12.4 kg, height was 157 ± 9 cm, BMI 24.6 ± 3.9 kg/m 2 , and waist circumference 88 ± 10.4 cm (92.0 ± 9.9 for men and 84.8 ± 9.6 for women). SBP and DBP were 138.2 ± 21.8 and 81.0 ± 12.0 mmHg, respectively. Mean values for serum fasting blood glucose, TGs, and HDL-C were 111.5 ± 31.9 mg/dL, 162.3 ± 136.2 mg/dL, and 53.6 ± 13.1 mg/dL (49.7 ± 12.7 for men and 56.8 ± 12.6 for women), respectively. According to NCEPwe, NCEPas, and IDF defi nitions, the prevalence of metabolic syndrome was, respectively, 46.5% (men 47.3% and women 45.8%), 56.5% (men 60.6% and women 53.1%), and 48.3% (men 48.6% and women 48.0%). The Venn diagram in Fig. 1 shows that for the 650 Japanese-Brazilians examined, 38.3% had metabolic syndrome according to all 3 defi nitions, whereas 43.5% did not have metabolic syndrome by all defi nitions, comprising a concordance of 81.8% among the 3 defi nitions. The frequency of subjects without metabolic syndrome In recent years, the defi nitions commonly used in metabolic syndrome diagnosis have been shown to be not appropriate for Japanese and Asian populations. In recognizing genetic differences in the risk factors for developing metabolic syndrome-related diseases between diverse ethnicities, the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), revising the National Cholesterol Evaluation Program for Adult Treatment Panel III (NCEP ATP III), 2 and the International Diabetes Federation (IDF) 8 established the same waist circumference cutoff values as proposed by the IDI for Japanese and other Asians to be used as criteria for defi ning metabolic syndrome in these populations.
There is a signifi cant Japanese population in Brazil. The study of metabolic syndrome prevalence according to different diagnosis criteria is particularly interesting in JapaneseBrazilians because they represent a combination of genetic backgrounds for developing metabolic syndrome and "westernization" of lifestyle. In fact, previous studies have shown a high prevalence of both glucose metabolism disturbances 9 and metabolic syndrome 10 in this population. However, a prior study on metabolic syndrome prevalence in JapaneseBrazilians used metabolic syndrome defi nitions from both the 1998 WHO criteria and a modifi ed set of 2001 NCEP criteria. 10 The WHO criteria, besides requiring evidence of insulin resistance for metabolic syndrome diagnosis, also included microalbuminuria evaluation and different cutoff values for metabolic syndrome components. 11 Because measures of insulin resistance and microalbuminuria are laborious, these criteria have not been used in more recent metabolic syndrome defi nitions. In the modifi ed 2001 NCEP defi nition, investigators used waist circumference values for Japanese; however, glucose cutoff values were ≥110 mg/dL and hypertension and dyslipidemia drug treatments were not taken into account. In this study, we compare the prevalence of metabolic syndrome in a Japanese-Brazilian population using defi nitions recently proposed by IDF 8 for Japanese (IDF) and NCEP ATP III 12 revised by the AHA/NHLBI 2 for Westerners (NCEPwe), and Asians (NCEPas).
Methods
Subjects
This study included 650 Japanese-Brazilians, 292 men (44.9%) and 358 women (55.1%), aged between 30 and 88 years (60.3 ± 12.5), all residing in the city of Bauru, São Paulo State, Brazil. The participants were invited by mail, announcements on television, and in newspapers. The protocol was approved by the Research Ethics Committee of São Paulo Federal University Clinical Hospital, and all subjects provided written informed consent at the time of their initial visit to the Health Education Clinic of Sacred Heart University, Bauru, São Paulo State.
Data collection
All data were collected between November, 2005, and February, 2006. The subjects participated in a medical interview and clinical examination. BMI was calculated as weight in kilograms divided by the square of height in meters (kg/ m 2 ). Waist circumference measurements were taken using a point equidistant between the lower border of the last rib triglycerides levels, 44.5%. The prevalence of altered metabolic syndrome components was substantially higher in individuals with waist circumferences above the recommended cutoff values for Asians than for those with normal circumferences, except for fasting blood glucose in male individuals (Table 2) . Table 3 shows the prevalence of altered metabolic syndrome components according to the distribution of different waist circumference values stratifi ed by gender. Altered fasting blood glucose or drug treatment prevalence was lower in women than in men at all similar waist circumferences, except for <80 cm. The prevalence of alteration in other metabolic syndrome risk factors was similar between men and women at the different waist circumferences, except for HDL, which was statistically higher in women at ≥85-and <90-cm waist circumferences.
Discussion
In this study we evaluated the prevalence of metabolic syndrome according to 3 different defi nitions in a population of Japanese-Brazilians living in a Brazilian city. Although there are several defi nitions of metabolic syndrome, we compared 3 widely used ones. These 3 are based on relatively similar components with differences in either cutoff values for waist circumference (NCEPwe ≠ NCEPas = IDF) or the requirement for abdominal obesity as 1 criterion (IDF). The main fi nding of this study is that, independent of the metabolic syndrome defi nition used, Japanese-Brazilians present an elevated metabolic syndrome prevalence (NCEPwe, 46.5%; NCEPas, 56.5%; and IDF, 48.3%).
The greatest metabolic syndrome prevalence was observed using NCEPas criteria, because it possesses lower cutoff values for waist circumference, similar to IDF. In contrast to IDF, however, NCEPas does not require the abdominal obesity component. Although in the NCEPwe defi nition the cutoff values for waist circumference are higher, metabolic syndrome prevalence was similar between IDF and NCEPwe defi nitions because NCEPwe does not require abdominal obesity to be present. The higher prevalence of metabolic syndrome by NCEPas than by IDF emphasizes that other components of metabolic syndrome may be present in the absence of abdominal obesity. It is important to point out that we measured waist circumference at the point midway between the inferior margin of the ribs and the superior border of the iliac crest, as recommended by IDF. 8 according to IDF criteria, but with metabolic syndrome by NCEPwe and NCEPas, was 8.2 %; metabolic syndrome prevalence by IDF and NCEPas, but without metabolics syndrome by NCEPwe, was 10.0%. Table 1 shows the prevalence of obesity (degrees I or II) in individuals with and without metabolic syndrome according to the different metabolic syndrome defi nitions. Subjects with metabolic syndrome according to all 3 defi nitions had a signifi cantly higher (76.7%) prevalence of obesity, followed by individuals with metabolic syndrome by IDF and NCEPas, but not according to NCEPwe (47.7%). The lowest obesity prevalences were found in subjects with metabolic syndrome by NCEPas and NCEPwe, but not by IDF (7.55%), and in individuals without metabolic syndrome by all 3 defi nitions (18.4%).
In our population, the prevalence of altered metabolic syndrome components was as follows: Waist circumference for Asians, 63.8%; waist circumference for Westerners, 25 syndrome prevalence in Japanese-Americans was 30.9% in men and 27.7% in women whereas in Japanese it was 13.4% in men and 14.4% in women. 15 The increased prevalence of metabolic syndrome seen in Japanese subjects living outside Japan probably illustrates the importance of lifestyle and its infl uence on metabolic syndrome development. Obesity, a key etiological factor for metabolic syndrome development, is directly infl uenced by nutritional habits. 16 As shown by Freire et al. 17 and Sartorelli et al., 18 the current dietary pattern of Japanese-Brazilians contrasts with the traditional Japanese diet, particularly concerning the higher proportion of fat and refi ned grains intake and very high consumption of fruits and fruit juices.
However, according to the revised NCEP ATP III, 2 waist circumference should be measured at the top of iliac crest. Therefore, it is possible that metabolic syndrome prevalence using NCEPwe and NCEPas could in fact be higher.
The prevalence of metabolic syndrome in JapaneseBrazilians is considerably higher than reported in the literature. In a recently published study in Japan, the metabolic syndrome prevalence using NCEPas and IDF for Japanese subjects was, respectively, 18.9% in men and 12.9% in women, and 11.4% in men and 11.6% in women, respectively. 14 The prevalence of metabolic syndrome in Japanese-Americans and Japanese living in Japan was evaluated by Yoneda et al. 15 With the revised NCEP III criteria for Wersterners, 2 metabolic Versus men with increased waist circumference (≥90 cm). Abbreviations: SD, standard deviation; BMI, body mass index; DT, drug treatment for the respective condition; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides. of altered fast blood glucose or drug treatment than women at all the waist circumference strata except for <80 cm.
The prevalence of altered metabolic syndrome components was high in this study. Reinforcing the environmental infl uence on the metabolic syndrome pathophysiology, Japanese subjects residing in Japan aged between 30 and 80 years (men 52.3 ± 9.0 and women 53.5 ± 9.0 years old) presented a considerably lower prevalence of altered metabolic syndrome components. Fasting glycemia ≥110 mg/dL was found in 24.8% of men and 10.9% of women, low HDL in 6.6% of men and 9.2% of women, high TGs in 30.4% of men and 9.9% of women, and high blood pressure in 43.9% of men and 34.5% of women. 26 It was alarming to observe that mean fasting glycemia values in our population were higher than the cutoff value of 100 mg/dL for both genders. It was also disconcerting to see that the number of individuals with elevated systemic blood pressure was higher than over 10 years before in fi rst-and second-generation Japanese-Brazilians (fi rst generation, 24.7% in men and 30.7% in women, and second generation, 28.7% in men and 30.9% in women). 27 Furthermore, Japanese-Brazilians present a higher prevalence of systemic arterial hypertension than the general Brazilian population. 28 In summary, in this study we used 3 different definitions to evaluate metabolic syndrome prevalence in Japanese-Brazilians living in a city of São Paulo State, Brazil. Independent of which defi nition was used, we found an elevated prevalence of metabolic syndrome in this population. Metabolic syndrome prevalence was highest when using the Asian NCEP criteria, followed by the Japanese IDF defi nition, with the Westerner NCEP criteria having the lowest prevalence. Additional studies are necessary to characterize the best defi nition of metabolic syndrome for Japanese subjects living outside Japan and exposed to different lifestyles.
Although interesting, the comparison between metabolic syndrome prevalence in Japanese-Brazilians and the native population is diffi cult because there are only a few studies, some with small sample sizes 19 and others with different criteria for defi ning metabolic syndrome. 20 Using IDF criteria for a South American population, which have the same waist circumference cutoff values as Asians, a metabolic syndrome prevalence of 17.9% was found in 140 health subjects. 19 With NCEP ATP III using waist circumference cutoff values for Westerners, a metabolic syndrome prevalence of 25.4% was observed in 1,507 individuals from an urban Brazilian population. 20 These prevalences are lower than in our study on Japanese-Brazilians, suggesting genetic factors infl uence the high metabolic syndrome prevalence of Japanese-Brazilians.
Increases in BMI are also considered measures of risk for co-morbidities. 21 Using the BMI classifi cation for Asians, we analyzed the prevalence of obesity I and II according to the different metabolic syndrome defi nitions. There was a high prevalence of obesity in those consistently diagnosed with metabolic syndrome by all 3 defi nitions (76.7%). In those concordant with metabolic syndrome defi nitions for Asians (NCEPas and IDF), but not for Westerners (NCEPwe), the obesity prevalence was also elevated (47.7%). Obviously, subjects without metabolic syndrome according to the IDF criteria, but with metabolic syndrome by the NCEPas and NCEPwe criteria, presented the lowest obesity prevalence (7.55%), because they did not have increased waist circumference. Because obesity is a fundamental factor for developing metabolic syndrome, these fi ndings suggest that the NCEPwe criteria should not be applied to Japanese-Brazilians. The 2000 National Nutrition Survey in Japan showed an overweight prevalence (BMI, 25.0-29.9 kg/m 2 ) of 24.5% for men and 17.8% for women and an obesity prevalence (BMI, ≥30.0 kg/m 2 ) of 2.3% for men and 3.4% for women. 22 If the BMI definition for Asians was taken into account, where those with BMI greater than 25.0 kg/m 2 are considered obese, the same National Nutrition Survey 22 would have shown an obesity prevalence of 26.8% in men and 21.2% in women. Obesity prevalence in our study was 51.7% for men and 35.5% for women (data not shown), which is much higher than in Japanese living in Japan.
As well as BMI, fat distribution also infl uences the risk of developing co-morbidities and cardiovascular morbimortality. 21, 23 In this study, the prevalence of elevated abdominal fat (63.8%) was high. If cutoff values for Westerners had been used, the elevated abdominal fat would have been 25.7%, which is still higher than the abdominal obesity prevalence seen in Japanese living in Japan (7.4%). 24 We showed that abdominal obesity contributed to metabolic abnormalities as the prevalence of altered metabolic syndrome components was substantially higher in individuals with waist circumferences above the recommended cutoff values than for those with normal circumferences. The waist circumference cutoff value as a criteria for metabolic syndrome in Japanese is still a matter of controversy. 25 Our data suggest that the <90-cm cutoff value for men may be high, because we observed a signifi cantly greater prevalence of altered metabolic syndrome components in men than women at normal waist circumference values (<90 cm for men and <80 cm for women). However, when evaluating the prevalence of altered metabolic syndrome components at similar waist circumferences, we observed that men presented a higher prevalence
